Age: 52.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Vaccination site warmth
Clinical narrative: swelling, redness and heat at injection site (lasted 5 days); swelling, redness and heat at injection site (lasted 5 days); swelling, redness and heat at injection site (lasted 5 days); extreme chills; night sweats; splitting headache; joint aches/left wrist and elbow hurt vs ached; swollen hands; left wrist and elbow hurt vs ached; eyes swollen; unstable balance; sleeping for extended lengths of time (11hours uninterrupted then 7hours); 48hours post migraine developed with headache; nausea; light/sound sensitivity; light/sound sensitivity; This is a spontaneous report received from a Consumer or other non HCP.  A 52-year-old female patient (not pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 29Oct2024 at 16:00 as dose 1, single (Lot number: LM2224) at the age of 52 years, in left arm for covid-19 immunisation; influenza vaccine (INFLUENZA), on 29Oct2024), in left arm. The patient's relevant medical history included: "Depression" (unspecified if ongoing). Concomitant medication(s) included: CITALOPRAM. The following information was reported: MIGRAINE (non-serious) with onset 30Oct2024 at 13:00, outcome "recovered" (02Nov2024), described as "48hours post migraine developed with headache"; CHILLS (non-serious) with onset 30Oct2024 at 13:00, outcome "recovered" (02Nov2024), described as "extreme chills"; EYE SWELLING (non-serious) with onset 30Oct2024 at 13:00, outcome "recovered" (02Nov2024), described as "eyes swollen"; ARTHRALGIA (non-serious) with onset 30Oct2024 at 13:00, outcome "recovered" (02Nov2024), described as "joint aches/left wrist and elbow hurt vs ached"; JOINT INJURY (non-serious) with onset 30Oct2024 at 13:00, outcome "recovered" (02Nov2024), described as "left wrist and elbow hurt vs ached"; HYPERACUSIS (non-serious), PHOTOPHOBIA (non-serious) all with onset 30Oct2024 at 13:00, outcome "recovered" (02Nov2024) and all described as "light/sound sensitivity"; NAUSEA (non-serious) with onset 30Oct2024 at 13:00, outcome "recovered" (02Nov2024); NIGHT SWEATS (non-serious) with onset 30Oct2024 at 13:00, outcome "recovered" (02Nov2024); HYPERSOMNIA (non-serious) with onset 30Oct2024 at 13:00, outcome "recovered" (02Nov2024), described as "sleeping for extended lengths of time (11hours uninterrupted then 7hours)"; HEADACHE (non-serious) with onset 30Oct2024 at 13:00, outcome "recovered" (02Nov2024), described as "splitting headache"; VACCINATION SITE SWELLING (non-serious), VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE WARMTH (non-serious) all with onset 30Oct2024 at 13:00, outcome "recovered" (02Nov2024) and all described as "swelling, redness and heat at injection site (lasted 5 days)"; PERIPHERAL SWELLING (non-serious) with onset 30Oct2024 at 13:00, outcome "recovered" (02Nov2024), described as "swollen hands"; BALANCE DISORDER (non-serious) with onset 30Oct2024 at 13:00, outcome "recovered" (02Nov2024), described as "unstable balance". Therapeutic measures were not taken as a result of vaccination site swelling, vaccination site erythema, vaccination site warmth, chills, night sweats, headache, arthralgia, peripheral swelling, joint injury, eye swelling, balance disorder, hypersomnia, migraine, nausea, hyperacusis, photophobia. Additional information: No allergy. The patient did not receive any other vaccines within 4 weeks prior to the vaccines that were reporting. The patient was taking any other medications within 2 weeks of the event starting. Swelling, redness and heat at injection site (lasted 5 days), extreme chills, night sweats, splitting headache, joint aches, swollen hands, left wrist and elbow hurt vs ached, eyes swollen, unstable balance, sleeping for extended lengths of time (11hours uninterrupted then 7hours), 48hours post migraine developed with headache, nausea, light/sound sensitivity.